The Early Treatment for Retinopathy of Prematurity Study (ETROP)
NCT00027222 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
The goal of the Early Treatment for Retinopathy of Prematurity Study (ETROP) is to test the hypothesis that earlier treatment in carefully selected cases will result in an overall better visual outcome than treatment at the conventional CRYO-ROP threshold point in the disease.
Conditions
- Retinopathy of Prematurity
Interventions
- PROCEDURE
-
retinal ablation
Sponsors & Collaborators
-
National Eye Institute (NEI)
lead NIH
Principal Investigators
-
William V. Good, M.D. · Smith-Kettlewell Eye Research Institute
Study Design
- Purpose
- TREATMENT
Eligibility
- Min Age
- 0 Years
- Max Age
- 42 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-10-31
Countries
- United States
Study Locations
More Related Trials
-
European Disease Registry on Retinopathy of Prematurity (ROP)
NCT04939571 ·Status: RECRUITING
-
Validation of i-ROP DL to Detect More Than Mild ROP
NCT06109285 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Stress Induced by Screening for Retinopathy of Prematurity - Should Speculum and Indentation Rather be Avoided
NCT04408807 ·Status: COMPLETED ·Phase: NA
-
The Incidence of Treatment-requiring Retinopathy of Prematurity in Greece
NCT05099588 ·Status: COMPLETED
-
WINROP Algorithm Validation for Retinopathy Screening in a Cohort of Premature Infants
NCT03347799 ·Status: COMPLETED
-
Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial
NCT05159960 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Effect of Multiple Non-pharmacological Methods for Pain Management During Eye Examination for Retinopathy of Prematurity in Preterm Infants
NCT06959290 ·Status: COMPLETED ·Phase: NA
-
A Prospective Study on the Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in Achieving >20% Intraocular Pressure (IOP) Reduction Without Medications at 6 Months in Naive, Untreated Glaucoma Patients
NCT07076303 ·Status: RECRUITING
-
IOP Pattern in Primary Angle Closure and Primary Angle Closure Glaucoma Patients, Before and After LPI
NCT01906151 ·Status: WITHDRAWN ·Phase: NA
-
Endoscopic Goniotomy for Infantile Glaucoma
NCT00338533 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Topically Applied Medical Therapy for the Treatment of Pediatric Glaucoma
NCT01527682 ·Status: COMPLETED ·Phase: PHASE2
-
ROP Check Database Premature Infant Outcomes
NCT07312669 ·Status: COMPLETED
-
Benchmarking Management of Glaucoma Using the Diopsys VEP/PERG Protocols.
NCT02594280 ·Status: UNKNOWN
-
IOP Reduction in Pigmentary Glaucoma Using DSLT
NCT07281391 ·Status: RECRUITING
-
Novel Drug Delivery Technique Via Retroject Device
NCT02051946 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Retinal Vascular Reactivity in Subjects With Newly Diagnosed Glaucoma Before and After Selective Laser Trabeculoplasty
NCT01209975 ·Status: UNKNOWN
-
Surgical Retinotomy for the Treatment of Glaucoma
NCT03798145 ·Status: WITHDRAWN ·Phase: NA
-
Phaco vs. Phaco-ELT vs. Phaco-Trabectome 12m
NCT01194310 ·Status: COMPLETED
-
Retinopathy of Prematurity:Summary of a Decade
NCT01363960 ·Status: COMPLETED
-
SDOCT-GMPE Software
NCT02235454 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Selective Laser Trabeculoplasty
NCT00347893 ·Status: UNKNOWN
-
Safety and Efficacy of Deep Wave Trabeculoplasty (DWT) in Primary Open Angle Glaucoma and Ocular Hypertension
NCT02226094 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Efficacy of 24-hour Intraocular Pressure Fluctuation Recording With the SENSIMED Triggerfish Contact Lens Sensor
NCT01390779 ·Status: COMPLETED ·Phase: NA
-
TF (SENSIMED Triggerfish) in Intraocular Anti-VEGF (Vascular Endothelial Growth Factor) Injection
NCT01983579 ·Status: TERMINATED ·Phase: PHASE4
-
Proteomic Profiles in Trabeculectomy Patients
NCT01841580 ·Status: COMPLETED